Go back to Newsroom

Dr. Paul VanVeldhuisen Named Chief Operating Officer of The Emmes Corporation

Company News

<p>The Emmes Corporation today announced that Dr. Paul VanVeldhuisen has been promoted to the newly created position of chief operating officer. Dr. VanVeldhuisen, who started at Emmes as a statistician and epidemiologist, will assume the additional leadership responsibilities while continuing to serve as principal investigator for government and privately funded research projects. </p>
<p>Dr. VanVeldhuisen joined the company in 1993 and was promoted to vice president in 2006. He is responsible for the scientific aspects of various research studies, including study design and analysis, and he oversees day-to-day operations of clinical trial support. Dr. VanVeldhuisen has contributed to research in important public health areas, including ophthalmology, drug abuse, organ transplantation and infectious disease. He also received the company’s Public Health Impact Award in 2013 for his team’s research on the safety of cesarean sections.</p>
<p>“I’m looking forward to my new role,” noted Dr. VanVeldhuisen. “What has stayed consistent during my 22 years here is our commitment to provide critical services that address important issues in public health. We’re involved in long-term studies on childhood cancer, clinical trials of HIV vaccines, vaccine trials associated with a pandemic threat, studies aimed at preventing and treating vision loss, and research in real-world settings examining prevention and treatment of substance use. These are the kinds of challenges that inspire our staff to do their best. It’s the dedicated employees committed to Emmes’ mission that make this a remarkable place to work.”</p>

Download Press Release Go back to Newsroom